TBIQYR5018-Global Bacterial Vaginosis Drug Market Research Report 2019
- TBI693871
- February 11, 2019
- Global
- 102 pages
- QY Market Research
Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria.
The classification of bacterial vaginosis drug includes Rx and OTC, and the proportion of OTC in 2016 is about 72%.
Bacterial vaginosis drug is widely sold in hospital, pharmacy and other field. The most proportion of bacterial vaginosis drug is sold in pharmacy, and the revenue in 2016 is about 423 M USD.
USA region is the largest supplier of bacterial vaginosis drug, with a revenue market share nearly 32% in 2016. Europe is the second largest supplier of Bacterial Vaginosis Drug, enjoying revenue market share nearly 30% in 2016.
USA and Europe are the largest consumption places, with the consumption market share nearly 28% in 2016.
Market competition is intense. Bayer, Pfizer, Sanofi, Piramal, Abbott, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Bacterial Vaginosis Drug market is valued at 800 million US$ in 2018 is expected to reach 1030 million US$ by the end of 2025, growing at a CAGR of 3.2% during 2019-2025.
This report focuses on Bacterial Vaginosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bacterial Vaginosis Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Bayer
Pfizer
Sanofi
Piramal
Abbott
Galderma
Mission
Alkem
Xiuzheng
Teva
Perrigo
West-Ward
HPGC
Yunnan Baiyao
Starpharma
Novel
Edenvridge
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Rx
OTC
Segment by Application
Hospital
Pharmacy
Other
Table of Contents
Executive Summary
1 Bacterial Vaginosis Drug Market Overview
1.1 Product Overview and Scope of Bacterial Vaginosis Drug
1.2 Bacterial Vaginosis Drug Segment by Type
1.2.1 Global Bacterial Vaginosis Drug Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Rx
1.2.3 OTC
1.3 Bacterial Vaginosis Drug Segment by Application
1.3.1 Bacterial Vaginosis Drug Consumption Comparison by Application (2014-2025)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.3 Global Bacterial Vaginosis Drug Market by Region
1.3.1 Global Bacterial Vaginosis Drug Market Size Region
1.3.2 North America Status and Prospect (2014-2025)
1.3.3 Europe Status and Prospect (2014-2025)
1.3.4 China Status and Prospect (2014-2025)
1.3.5 Japan Status and Prospect (2014-2025)
1.3.6 Southeast Asia Status and Prospect (2014-2025)
1.3.7 India Status and Prospect (2014-2025)
1.4 Global Bacterial Vaginosis Drug Market Size
1.4.1 Global Bacterial Vaginosis Drug Revenue (2014-2025)
1.4.2 Global Bacterial Vaginosis Drug Production (2014-2025)
2 Global Bacterial Vaginosis Drug Market Competition by Manufacturers
2.1 Global Bacterial Vaginosis Drug Production Market Share by Manufacturers (2014-2019)
2.2 Global Bacterial Vaginosis Drug Revenue Share by Manufacturers (2014-2019)
2.3 Global Bacterial Vaginosis Drug Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Bacterial Vaginosis Drug Production Sites, Area Served, Product Types
2.5 Bacterial Vaginosis Drug Market Competitive Situation and Trends
2.5.1 Bacterial Vaginosis Drug Market Concentration Rate
2.5.2 Bacterial Vaginosis Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Bacterial Vaginosis Drug Production Market Share by Regions
3.1 Global Bacterial Vaginosis Drug Production Market Share by Regions
3.2 Global Bacterial Vaginosis Drug Revenue Market Share by Regions (2014-2019)
3.3 Global Bacterial Vaginosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Bacterial Vaginosis Drug Production
...
| read more...
Related Reports
Global Bacteriological Testing Market 2021 (Includes Business Impact of COVID-19)
Published : 16, September
Published : 16, September